Our greatest asset is our people, whose extensive industry knowledge drives our thought leadership on the most relevant topics. We are forward-thinking leaders, providing insights, perspectives, and case studies that address the key challenges facing the industry today. Explore our content to discover how we help navigate and overcome these challenges.
Leadership is the #1 success factor in change and the #1 reason why it fails. It will either drive transformation or become its greatest barrier. Across every level – senior, middle and front-line – leaders hold the power to accelerate progress or bring it to a halt.
AI dominates headlines, boardrooms, and strategy sessions. But there’s a glaring disconnect between AI’s promises and the tangible value enterprises gain. Arcondis encountered significant barriers and a persistent gap between AI’s transformative promises and measurable enterprise outcomes. These challenges led Arcondis to building our own solution.
Imagine stepping into a hospital and being greeted not by a doctor, but by an AI-powered agent. Today, big tech pioneers race toward this future vision that will be built on agentic AI workflows. Yet without rigorous validation, this promising vision leads to uncertainty. Would you trust your health in a future that is untested?
In boardrooms around the world, change management is still often treated as an “afterthought” – something to “layer on” after the technology is selected, the budget approved and the plan in motion. But in today’s world, where transformation is the rule rather than the exception, this mindset is a critical and costly mistake.
Is Real-world Evidence (RWE) the new gold standard for data generation? Our latest whitepaper investigates how RWE is transforming the pharma industry, offering a future-proof, cost-effective approach to drug approval and market access.
Expecting a Maximo team to become OpenShift experts can be a challenging approach. Specialised tools require specialised expertise and investing in a dedicated OpenShift team ensures both technologies deliver their full value without compromise. This is where a Managed Services Provider (MSP) can fill the gap.
Digital transformation is revolutionising life sciences labs with AI, automation, and robotics, boosting efficiency and discovery. But can labs truly operate without humans? Explore the future of autonomous labs, the challenges ahead, and why human-machine collaboration is key.
Pharma companies must decide whether to in-source AI-powered content creation for control and compliance or outsource for speed and expertise. Explore how Gen AI is reshaping HCP content workflows, the risks and benefits of different approaches, and how companies can cut content-related costs by up to 40%.
Digital therapeutics are transforming healthcare by turning smartphones and wearables into personalised treatment tools, breaking down access barriers, and proving what real-time data can deliver. Better outcomes—anytime, anywhere.
Effective data management helps healthcare organisations reduce costs, stay competitive, and support AI and IoT. Prioritising data capture, storage, and analysis optimises resources and enhances value-based care.
Despite years of striving for customer-centricity and promoting omnichannel strategies, the pharma industry has made little progress. While efforts have been made to integrate patient and healthcare provider needs into their strategies, many companies still struggle to deliver seamless, personalised experiences across channels.
In just two months, ChatGPT attracted an impressive 100-million users, far exceeding the record for the fastest user registration on any platform to date. This rapid adoption shows the widespread recognition of Artificial Intelligence’s (AI) potential across various industry sectors – including MedTech.
In the traditional landscape of the life sciences industry, validation processes have long been synonymous with mountains of paperwork. However, as technology continues to evolve, a transformative shift is underway – the era of paperless validation.
Today’s online digital services across a broad range of industries offer a level of engagement and customer experience that few could have imagined a decade ago.
The last century saw rapid progress in medical treatments. Early successes include antibiotics and chemical compounds like Aspirin. More recent breakthroughs in “biologics” like antibodies, cells and RNA-based therapies have expanded treatment options for complex diseases.
A quarter of the 21st century has passed, yet we still don’t have widely avai- lable and affordable personalised precision medicine. It is high time that we correctly utilise the innovation and progress in medical technology to create new workflows and standards of care.
Advisors can play a significant role in helping start-ups succeed, but it is not always clear what the role is that advisors play and whether start-ups really need them.
While global environmental change, including climate change, is now widely recognised, the healthcare sector has only recently begun to fully acknow- ledge its impact on the environment.
